Back

Elevated biomarkers are associated with increased risk of death and heart failure hospitalization in patients with atrial fibrillation: insights from the ARISTOTLE trial

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome 2 Heart Failure in Atrial Fibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

8 More presentations in this session

Presentation thumbnail
Relationship between diabetes mellitus and a risk of heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF registry
Doctor M. Ishii (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Relationship between structural brain damage and cognitive function in patients with atrial fibrillation
Doctor S. Aeschbacher (Basel, CH)
Abstract
Presentation thumbnail
Comparison of effectiveness, safety, and healthcare costs in non-valvular atrial fibrillation patients with heart failure prescribed direct oral anticoagulants
Miss A. Bassalobre Garcia (Morrisville, US)
Abstract Slides
Presentation thumbnail
Physical activity and outcome in patients with atrial fibrillation
Doctor R. Brenner (St. Gallen, CH)
Abstract Slides
Presentation thumbnail
Long-term clinical impact of sinus rhythm restoration in atrial fibrillation patients with heart failure with mid-ranged ejection fraction
Associate Professor Y. Baek (Incheon, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome 2

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources